Farmacia
Facultat
MARÍA ISABEL
FABREGAT ROMERO
Profesora titular de universidad
Publicacions en què col·labora amb MARÍA ISABEL FABREGAT ROMERO (72)
2022
-
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory response
Journal of Pathology, Vol. 258, Núm. 3, pp. 312-324
-
Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals
Hepatology, Vol. 75, Núm. 3, pp. 550-566
2020
-
A Signaling Crosstalk between BMP9 and HGF/c-Met Regulates Mouse Adult Liver Progenitor Cell Survival
Cells, Vol. 9, Núm. 3
-
Case Report: An EGFR-Targeted 4-1BB-agonistic Trimerbody Does Not Induce Hepatotoxicity in Transgenic Mice With Liver Expression of Human EGFR
Frontiers in Immunology, Vol. 11
-
Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer
Journal of Hepatology, Vol. 72, Núm. 1, pp. 125-134
-
Editorial Special Issue TGF-beta/BMP Signaling Pathway
Cells
2019
2018
-
Bone morphogenetic protein 9 as a key regulator of liver progenitor cells in DDC-induced cholestatic liver injury
Liver International, Vol. 38, Núm. 9, pp. 1664-1675
-
Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” (Redox Biol. (2017) 13 (94–162)(S2213231717303373)(10.1016/j.redox.2017.05.007))
Redox Biology
2017
-
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Redox Biology, Vol. 13, pp. 94-162
2016
-
Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1
The FEBS journal, Vol. 283, Núm. 7, pp. 1300-1310
-
Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesis
Hepatology, Vol. 63, Núm. 2, pp. 604-619
-
TGF-β signalling and liver disease
FEBS Journal, pp. 2219-2232
-
The rationale for targeting TGF-β in chronic liver diseases
European Journal of Clinical Investigation, Vol. 46, Núm. 4, pp. 349-361
2015
-
BMP9-induced survival effect in liver tumor cells requires p38MAPK activation
International Journal of Molecular Sciences, Vol. 16, Núm. 9, pp. 20431-20448
-
HGF/c-Met signaling promotes liver progenitor cell migration and invasion by an epithelial-mesenchymal transition-independent, phosphatidyl inositol-3 kinase-dependent pathway in an in vitro model
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1853, Núm. 10, pp. 2453-2463
2014
-
Caveolin-1 is required for TGF-ß-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17
Cell Death and Disease, Vol. 5, Núm. 7
-
Polμ deficiency increases resistance to oxidative damage and delays liver aging
PLoS ONE, Vol. 9, Núm. 4
-
The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression
Free Radical Biology and Medicine, Vol. 69, pp. 338-347
2013
-
BMP9 Is a Proliferative and Survival Factor for Human Hepatocellular Carcinoma Cells
PLoS ONE, Vol. 8, Núm. 7